130 related articles for article (PubMed ID: 38113633)
1. Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis.
Nishio S; Murotani K; Yamagami W; Suzuki S; Nakai H; Kato K; Tokunaga H; Nomura H; Yokoyama Y; Takehara K; Okamoto A
Gynecol Oncol; 2024 Feb; 181():46-53. PubMed ID: 38113633
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
Yang N; Han X; Yu J; Shu W; Qiu F; Han J
J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
4. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
5. Correlation analysis of hemoglobin, albumin, lymphocyte, platelet score and platelet to albumin ratio and prognosis in patients with lung adenosquamous carcinoma.
Zhang T; Liu W; Xu C
Front Oncol; 2023; 13():1166802. PubMed ID: 37746281
[TBL] [Abstract][Full Text] [Related]
6. The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma.
Solmaz S; Uzun O; Sevindik OG; Demirkan F; Ozcan MA; Ozsan GH; Alacacıoglu I
Int J Lab Hematol; 2023 Feb; 45(1):13-19. PubMed ID: 36053932
[TBL] [Abstract][Full Text] [Related]
7. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
[TBL] [Abstract][Full Text] [Related]
8. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery.
Zhang D; Zeng H; Pan Y; Zhao Y; Wang X; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Chen M; Hu D
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556261
[TBL] [Abstract][Full Text] [Related]
9. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the Cutoffs for HALP in Endometrial Cancer.
Wang J; Jiang P; Huang Y; Tu Y; Zhou Q; Li N; Kong W; Yuan R
Am J Clin Oncol; 2023 Mar; 46(3):107-113. PubMed ID: 36700534
[TBL] [Abstract][Full Text] [Related]
11. The analysis of the prognostic value of the neutrophil/ lymphocyte ratio and the platelet/lymphocyte ratio among advanced endometrial cancer patients.
Muzykiewicz KP; Iwanska E; Janeczek M; Glanowska I; Karolewski K; Blecharz P
Ginekol Pol; 2021; 92(1):16-23. PubMed ID: 33448001
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of HALP score and combination of peripheral blood multiple indicators in patients with early breast cancer.
Zhao Z; Xu L
Front Oncol; 2023; 13():1253895. PubMed ID: 38188308
[TBL] [Abstract][Full Text] [Related]
13. The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Patients with Small Cell Lung Cancer Before First-Line Treatment with Etoposide and Progression-Free Survival.
Shen XB; Zhang YX; Wang W; Pan YY
Med Sci Monit; 2019 Jul; 25():5630-5639. PubMed ID: 31356586
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Jia W; Yuan L; Ni H; Xu B; Zhao P
Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of hemoglobin, albumin, lymphocyte, and platelet indexes in predicting lymph node metastasis and recurrence of endometrial cancer: a retrospective study.
Xiong Y; Yong Y; Wang Y
PeerJ; 2023; 11():e16043. PubMed ID: 37786581
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Metastatic Colorectal Cancer.
Bulut G; Ozdemir ZN
J Gastrointest Cancer; 2022 Mar; 53(1):1-6. PubMed ID: 33686459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
